Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea
· Delayed Price · Currency is KRW 8,170.00
-30.00 (-0.37%)
At close: Apr 29, 2026
Ahn-Gook Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 93,196 | 96,151 | 74,216 | 106,948 | 104,448 | 122,613 | Upgrade
|
| Market Cap Growth | 28.53% | 29.56% | -30.61% | 2.39% | -14.82% | -17.69% | Upgrade
|
| Enterprise Value | 113,135 | 114,723 | 118,816 | 100,255 | 81,429 | 96,410 | Upgrade
|
| Last Close Price | 8200.00 | 8460.00 | 6074.77 | 8177.38 | 7791.85 | 8865.08 | Upgrade
|
| PE Ratio | 12.46 | 12.85 | 4.41 | 82.90 | 15.19 | 31.13 | Upgrade
|
| Forward PE | - | 71.34 | 71.34 | 71.34 | 71.34 | 71.34 | Upgrade
|
| PS Ratio | 0.30 | 0.31 | 0.27 | 0.46 | 0.51 | 0.75 | Upgrade
|
| PB Ratio | 0.56 | 0.58 | 0.45 | 0.71 | 0.68 | 0.80 | Upgrade
|
| P/TBV Ratio | 0.59 | 0.61 | 0.46 | 0.72 | 0.69 | 0.82 | Upgrade
|
| P/FCF Ratio | 2.50 | 2.58 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 2.04 | 2.11 | 15.10 | - | 58.40 | 83.29 | Upgrade
|
| EV/Sales Ratio | 0.37 | 0.37 | 0.44 | 0.43 | 0.40 | 0.59 | Upgrade
|
| EV/EBITDA Ratio | 6.29 | 6.18 | 8.27 | 9.94 | 5.69 | 28.16 | Upgrade
|
| EV/EBIT Ratio | 12.27 | 11.71 | 17.79 | 19.81 | 8.68 | - | Upgrade
|
| EV/FCF Ratio | 3.04 | 3.08 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.44 | 0.44 | 0.47 | 0.12 | 0.13 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 3.93 | 3.93 | 5.41 | 1.75 | 1.40 | 5.90 | Upgrade
|
| Debt / FCF Ratio | 1.96 | 1.96 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | 0.11 | 0.29 | -0.12 | -0.12 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.02 | 1.02 | 3.34 | -1.76 | -1.29 | -7.97 | Upgrade
|
| Net Debt / FCF Ratio | 0.51 | 0.51 | -0.68 | 2.61 | 16.14 | 10.64 | Upgrade
|
| Asset Turnover | 1.00 | 1.00 | 1.00 | 1.01 | 0.93 | 0.77 | Upgrade
|
| Inventory Turnover | 2.22 | 2.22 | 2.57 | 2.99 | 3.13 | 2.69 | Upgrade
|
| Quick Ratio | 1.00 | 1.00 | 1.15 | 1.25 | 1.53 | 1.75 | Upgrade
|
| Current Ratio | 1.65 | 1.65 | 1.75 | 1.73 | 1.98 | 2.23 | Upgrade
|
| Return on Equity (ROE) | 4.42% | 4.42% | 10.33% | 0.65% | 4.47% | 2.47% | Upgrade
|
| Return on Assets (ROA) | 2.00% | 2.00% | 1.54% | 1.37% | 2.64% | -0.32% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.99% | 4.67% | 3.11% | 0.88% | 6.67% | -0.87% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.30% | 4.30% | 3.00% | 3.20% | 5.80% | -0.60% | Upgrade
|
| Earnings Yield | 8.03% | 7.78% | 22.70% | 1.21% | 6.58% | 3.21% | Upgrade
|
| FCF Yield | 39.94% | 38.71% | -95.63% | -6.36% | -1.09% | -2.09% | Upgrade
|
| Payout Ratio | 66.85% | 66.85% | 14.84% | 193.81% | 36.52% | 64.00% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -0.02% | -0.01% | 0.12% | 0.65% | 9.44% | Upgrade
|
| Total Shareholder Return | 5.35% | -0.02% | -0.01% | 0.12% | 0.65% | 9.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.